Soumya D Chakravarty MD PhD, FACP, FACR
Senior Director, Strategic Lead, Rheumatology Medical Affairs
Join to View Full Profile
850 Ridgeview DriveHorsham, PA 19044
Dr. Chakravarty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Soumya Chakravarty is a Rheumatology specialist based in Horsham, PA. He obtained his MD, PhD from Albert Einstein College of Medicine in 2008 and furthered his training in Internal Medicine and Rheumatology at New York Presbyterian Hospital (Cornell Campus) and Hospital for Special Surgery. His professional experience includes roles at Johnson and Johnson, Drexel University College of Medicine, Hahnemann University Hospital, and a volunteer position at Tower Health Reading Hospital. Dr. Chakravarty's expertise lies in the treatment of psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, systemic lupus erythematosus, sjogren's disease, and osteoarthritis. He has made several contributions to the medical literature and was a recipient of the Scientist Development Award from the Rheumatology Research Foundation in 2012-2014.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 2010 - 2014- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2008 - 2010
Albert Einstein College of MedicineClass of 2008, MD, PhD
Certifications & Licensure
HI State Medical License 2024 - 2026
NY State Medical License 2009 - 2026
PA State Medical License 2013 - 2026
NJ State Medical License 2014 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Recipient, Scientist Development Award Rheumatology Research Foundation, 2012-2014
Publications & Presentations
PubMed
- Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLU...Alexis Ogdie, Soumya M Reddy, Sarah H Gillespie, M Elaine Husni, Jose U Scher
Trials. 2025-03-19 - Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors.Philip J Mease, Shannon A Ferrante, Natalie J Shiff, Timothy P Fitzgerald, Soumya D Chakravarty
Advances in Therapy. 2025-02-01 - 1 citationsPersistent Patient-Level Effect of Guselkumab at Consecutive 8-Week Dosing Visits and Over Time in Patients With Active Psoriatic Arthritis: Post Hoc Analysis of a 2-Y...Philip J Mease, Xenofon Baraliakos, Vinod Chandran, Enrique R Soriano, Peter Nash
ACR Open Rheumatology. 2024-12-01
Professional Memberships
- Fellow
- Fellow
Other Languages
- Bengali
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
